EnteroMedics raises about $12 million for obesity device

03/5/2013 | MassDevice.com (Boston)

EnteroMedics has raised net proceeds of about $12 million in a public offering. The St. Paul, Minn.-based company will use the money to seek FDA approval for its Maestro RC system, which uses vagal nerve blocking to help treat patients with obesity, as well as to market the product outside the U.S.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC